Takeru Funakoshi

2.6k total citations
83 papers, 1.4k citations indexed

About

Takeru Funakoshi is a scholar working on Oncology, Dermatology and Immunology. According to data from OpenAlex, Takeru Funakoshi has authored 83 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Oncology, 29 papers in Dermatology and 21 papers in Immunology. Recurrent topics in Takeru Funakoshi's work include Cancer and Skin Lesions (23 papers), Immunotherapy and Immune Responses (17 papers) and Cancer Immunotherapy and Biomarkers (17 papers). Takeru Funakoshi is often cited by papers focused on Cancer and Skin Lesions (23 papers), Immunotherapy and Immune Responses (17 papers) and Cancer Immunotherapy and Biomarkers (17 papers). Takeru Funakoshi collaborates with scholars based in Japan, United States and United Kingdom. Takeru Funakoshi's co-authors include Masayuki Amagai, Keitaro Fukuda, Keiji Tanese, Yoshio Nakamura, Ikuko Hirai, Yasuhiro Fujisawa, Yutaka Kawakami, Taku Fujimura, Hiroo Hata and Yuki Yamamoto and has published in prestigious journals such as Nature Medicine, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Takeru Funakoshi

76 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takeru Funakoshi Japan 20 791 510 315 201 197 83 1.4k
Mohamed H. Zaki United States 19 607 0.8× 301 0.6× 609 1.9× 166 0.8× 145 0.7× 77 1.3k
Jeong Hee Cho‐Vega United States 18 581 0.7× 156 0.3× 512 1.6× 103 0.5× 168 0.9× 44 1.4k
Paul Drillenburg Netherlands 20 442 0.6× 313 0.6× 374 1.2× 175 0.9× 176 0.9× 37 1.4k
Kyri Dunussi‐Joannopoulos United States 17 312 0.4× 1.6k 3.2× 245 0.8× 69 0.3× 194 1.0× 19 2.1k
A. Brocard France 21 727 0.9× 283 0.6× 295 0.9× 116 0.6× 505 2.6× 51 1.4k
Pamela A. Groben United States 20 460 0.6× 184 0.4× 406 1.3× 81 0.4× 233 1.2× 51 1.3k
Jorge Santos‐Juanes Spain 20 271 0.3× 601 1.2× 162 0.5× 54 0.3× 256 1.3× 102 1.2k
Tie Zheng Hou United Kingdom 17 863 1.1× 1.7k 3.2× 256 0.8× 103 0.5× 227 1.2× 20 2.3k
Anupam M. Desai United States 7 1.3k 1.6× 870 1.7× 357 1.1× 311 1.5× 126 0.6× 11 1.9k
Yoshikata Misaki Japan 19 247 0.3× 809 1.6× 221 0.7× 112 0.6× 111 0.6× 38 1.3k

Countries citing papers authored by Takeru Funakoshi

Since Specialization
Citations

This map shows the geographic impact of Takeru Funakoshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takeru Funakoshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takeru Funakoshi more than expected).

Fields of papers citing papers by Takeru Funakoshi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takeru Funakoshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takeru Funakoshi. The network helps show where Takeru Funakoshi may publish in the future.

Co-authorship network of co-authors of Takeru Funakoshi

This figure shows the co-authorship network connecting the top 25 collaborators of Takeru Funakoshi. A scholar is included among the top collaborators of Takeru Funakoshi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takeru Funakoshi. Takeru Funakoshi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Adachi, Takeya, Chiaki Takahashi, Yoshio Nakamura, et al.. (2024). Delayed and immediate cutaneous adverse events during pembrolizumab combination chemotherapy against cervical cancer: Case series. The Journal of Dermatology. 52(1). 132–137. 1 indexed citations
2.
Yanagi, Teruki, Takuya Maeda, Hiroshi Nishihara, et al.. (2024). Establishment of a trastuzumab-resistant extramammary Paget disease model: loss of PTEN as a potential mechanism. British Journal of Cancer. 131(5). 944–953. 2 indexed citations
3.
Saito, Takuro, Takashi Kojima, Takeru Funakoshi, et al.. (2023). Integrated analysis of phase 1a and 1b randomized controlled trials; Treg-targeted cancer immunotherapy with the humanized anti-CCR4 antibody, KW-0761, for advanced solid tumors. PLoS ONE. 18(9). e0291772–e0291772. 11 indexed citations
4.
Tanaka, Ryo, Shohei Egami, Takeshi Ouchi, et al.. (2022). Clinical severity scores as a guide for prediction of initial treatment responses in pemphigus and pemphigoid patients. The Journal of Dermatology. 50(2). 203–211. 2 indexed citations
5.
Yamagami, Jun, Takeru Funakoshi, Ryo Tanaka, et al.. (2022). Rituximab therapy for intractable pemphigus: A multicenter, open‐label, single‐arm, prospective study of 20 Japanese patients. The Journal of Dermatology. 50(2). 175–182. 4 indexed citations
6.
Maeda, Yuka, Hisashi Wada, Daisuke Sugiyama, et al.. (2021). Depletion of central memory CD8+ T cells might impede the antitumor therapeutic effect of Mogamulizumab. Nature Communications. 12(1). 7280–7280. 29 indexed citations
7.
Zhao, Wenling, Ken Ishii, Shohei Egami, et al.. (2021). Analysis of clinical characteristics, prognosis and antibody pathogenicity of pemphigus patients positive for anti‐desmoglein IgG autoantibodies in remission: a retrospective cohort study. Journal of the European Academy of Dermatology and Venereology. 36(2). 271–278. 6 indexed citations
8.
Fukuda, Keitaro, Ken Okamura, Rebecca L. Riding, et al.. (2021). AIM2 regulates anti-tumor immunity and is a viable therapeutic target for melanoma. The Journal of Experimental Medicine. 218(9). 57 indexed citations
9.
Shimozaki, Keitaro, Kenro Hirata, Yukie Hayashi, et al.. (2021). The Entire Intestinal Tract Surveillance Using Capsule Endoscopy after Immune Checkpoint Inhibitor Administration: A Prospective Observational Study. Diagnostics. 11(3). 543–543. 2 indexed citations
10.
Hirai, Ikuko, Keiji Tanese, Yoshio Nakamura, et al.. (2020). Anti-PD-1 antibody therapy for epithelial skin malignancies. Medicine. 99(44). e22913–e22913. 10 indexed citations
11.
Otsuka, Atsushi, Masahiro Hirata, Tatsuki R. Kataoka, et al.. (2019). Variable indoleamine 2,3‐dioxygenase expression in acral/mucosal melanoma and its possible link to immunotherapy. Cancer Science. 110(11). 3434–3441. 13 indexed citations
12.
Otsuka, Atsushi, Yosuke Yamamoto, Chisa Nakashima, et al.. (2019). Accumulation of exhausted CD8+ T cells in extramammary Paget’s disease. PLoS ONE. 14(1). e0211135–e0211135. 11 indexed citations
13.
Tanese, Keiji, Yoshio Nakamura, Ikuko Hirai, & Takeru Funakoshi. (2019). Updates on the Systemic Treatment of Advanced Non-melanoma Skin Cancer. Frontiers in Medicine. 6. 160–160. 28 indexed citations
14.
Fujisawa, Yasuhiro, Kenji Yoshino, Taku Fujimura, et al.. (2019). The efficacy of eribulin methylate for patients with taxane-resistant cutaneous angiosarcoma: Final results from a multi-center, prospective, observational study. Annals of Oncology. 30. ix135–ix135. 1 indexed citations
15.
Hirai, Ikuko, Keiji Tanese, Yoshio Nakamura, et al.. (2018). Assessment of the methods used to detect HER2-positive advanced extramammary Paget’s disease. Medical Oncology. 35(6). 92–92. 11 indexed citations
16.
17.
Iwanami, Akio, Takeru Funakoshi, Shuji Mikami, et al.. (2018). Multifocal primary melanoma of the cervical spinal cord successfully treated by tumorectomy: a case report. Spinal Cord Series and Cases. 4(1). 24–24. 5 indexed citations
18.
Funakoshi, Takeru, Mayumi Mori, Katsura Emoto, et al.. (2017). Expression of monoacylglycerol lipase as a marker of tumour invasion and progression in malignant melanoma. Journal of the European Academy of Dermatology and Venereology. 31(12). 2038–2045. 27 indexed citations
19.
Kurose, Koji, Yoshihiro Ohue, Hisashi Wada, et al.. (2015). Phase Ia Study of FoxP3+ CD4 Treg Depletion by Infusion of a Humanized Anti-CCR4 Antibody, KW-0761, in Cancer Patients. Clinical Cancer Research. 21(19). 4327–4336. 179 indexed citations
20.
Funakoshi, Takeru, Yuko Kazumi, Koshiro Nishimoto, et al.. (2009). Intractable ulcer caused byMycobacterium shinshuense: successful identification of mycobacterium strain by 16S ribosomal RNA 3â²-end sequencing. Clinical and Experimental Dermatology. 34(8). e712–e715. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mohamed H. Zaki Breakdown of academic impact, for papers by Jeong Hee Cho‐Vega Breakdown of academic impact, for papers by Paul Drillenburg Breakdown of academic impact, for papers by Kyri Dunussi‐Joannopoulos Breakdown of academic impact, for papers by A. Brocard Breakdown of academic impact, for papers by Pamela A. Groben Breakdown of academic impact, for papers by Jorge Santos‐Juanes Breakdown of academic impact, for papers by Tie Zheng Hou Breakdown of academic impact, for papers by Anupam M. Desai Breakdown of academic impact, for papers by Yoshikata Misaki
Rankless by CCL
2026